Pharmac Message on Mesalazine Tablets
Posted Wednesday September 3, 2025
From 1 July 2025 Pharmac listed Mesalazine 1600mg tablets, Asacol brand.
Due to the current shortage of mesalazine 400mg tablets please consider prescribing mesalazine 1600mg for patients that are taking a 1600mg dose.
This is a Section 29 (unapproved) medicine.
Additional information can be found here - Mesalazine tablets Pharmac website
Gallery
Related Articles
NZSG Executive Committee Nominations are Open
Monday October 13, 2025
Joining the Executive Committee is a chance to help shape the future of gastroenterology and make a meaningful contribut...
Register Now for THE NZSG Annual Scientific Meeting
Sunday October 12, 2025
Join us for leading educational presentations and great social events. Meet colleagues, talk to our sponsors, and share ...
New Zealand Committee for the Recognition of Training in Gastrointestinal Endoscopy. Notice of AGM on 27 November 2025
Friday October 10, 2025
This is a notice of our upcoming AGM, at which time there will be three resolutions (below) concerning the structure of ...